Summary
Despite its ubiquity in cosmetic circles and broad general awareness, a literature
search of botulinum neurotoxin in JPRAS and BJPS yielded a mere 4 articles germane to cosmesis. A pair each detailing
its application in masseteric hypertrophy
1
,
2
and the use of cryoanalgesia.
3
,
4
Given that botulinum neurotoxin A is the most commonly used cosmetic treatment, with
American figures being most accurate,
a review of the background, development and scientific evidence would be perhaps
useful, if not overdue, as Plastic Surgeons increasingly incorporate non-surgical
interventions into their practices as part of a comprehensive facial rejuvenation
strategy.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Plastic, Reconstructive & Aesthetic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.Br J Plast Surg. 2001; 54: 197-200
- Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.J Plast Reconstr Aesthet Surg. 2010; 63: 2026-2031
- Beneficial use of an ice-balloon as part of botulinum toxin type A therapy for facial dynamic wrinkles and other skin injection procedures.Br J Plast Surg. 2003; 56: 619
- Botulinum toxin injection pain relief using a topical anesthetic skin refrigerant.J Plast Reconstr Aesthet Surg. 2010; 63: 1443-1446
http://www.plasticsurgery.org/Documents/news-resources/statistics/2010-statisticss/Overall-Trends/2010-cosmetic-plastic-surgery-minimally-invasive-statistics.pdf; [accessed 06.11.11].
- Botulinum toxin as a biological weapon: medical and public health management.JAMA. 2001; 285: 1059-1070
- Historical notes on botulism, Clostridium botulinum, botulinum toxin and the idea of the therapeutic use of the toxin.Mov Disord. 2004; 19: S2-S6
- Über einen neuen anaëroben Bacillus and seine Beziehungen zum Botulismus.Z Hyg Infektionskrankh. 1897; 26: 1-56
- The action of botulinum toxin on the neuro-muscular junction.J Physiol. 1949; 109: 10-24
- A higher form of killing: the secret history of chemical and biological warfare.Chatto & Windus, London1982
http://news.bbc.co.uk/1/hi/world/americas/244974.stm; [accessed 06.11.11].
- Botulinum toxin and sweating.J Neurol Neurosurg Psychiatry. 1994; 57: 1437-1438
- Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.Ophthalmology. 1980; 87: 1044-1049
- Botulinum toxin A injection as a treatment for blepharospasm.Arch Opththalmol. 1985; 103: 347-350
- Treatment of glabellar frown lines with C. botulinum-A exotoxin.J Dermatol Surg Oncol. 1992; 18: 17-21
- Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis: follow up.Plast Reconst Surg. 2005; 115: 573-574
- Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis.Plast Reconst Surg. 1989; 84: 353-355
- Botulinum A toxin (Oculinum) in ophthalmology.Surv Ophthalmol. 1991; 36: 28-46
- I will survive: DNA protection in bacterial spores.Trends Microbiol. 2007; 15: 172-180
- An overview of botulinum toxins: past, present, and future.Clin Plast Surg. 2011; 38: 409-426
- Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.Nat Struct Biol. 2003; 10: 13-18
- Neurotoxins affecting neuroexocytosis.Physiol Rev. 2000; 80: 717-766
- Botulinum toxin for blepharospasm: single-fibre EMG studies.Neurology. 1986; 36: 545-547
- Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.Proc Natl Acad Sci USA. 1999; 96: 3200-3205
- Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features.Neuroscience. 1990; 37: 799-808
- ([Chapter 5] pp. 83–92)Burgess C.M. Cosmetic dermatology. Springer, Heidelberg2005
- Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery.Plast Reconstr Surg. 2003; 112: 40S-52S
- A multicentre, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.J Am Acad Dermatol. 2004; 51: 223-233
- Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans.Plast Reconstr Surg. 2000; 105: 778-784
- Problems with toxins.Body Lang. 2010; 35: 43-44
- Saftey of botulinum toxin type A: a systematic review and meta-analysis.Curr Med Res Opin. 2004; 20: 981-990
- Systemic toxicity of botulinum toxin by intramuscular injection in the monkey.Mov Disord. 1988; 3: 333-335
- Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.J Am Acad Dermatol. 2005; 53: 407-415
- Fatal case of BOTOX-related anaphylaxis.J Forensic Sci. 2005; 50: 169-172
http://www.telegraph.co.uk/news/worldnews/northamerica/usa/1478282/Doctor-and-patients-fight-for-life-after-anti-wrinkle-jabs.html; [accessed 06.11.11].
- Botulinum toxin: influence on respiratory heart rate variation.Mov Dosord. 1995; 10: 574-579
- Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox).J Biomech. 2011; 44: 39-44
- Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety and antibody frequency.J Neurol. 1999; 246: 265-274
- Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications.Mov Disord. 2010; 15: 2211-2218
- Neutralizing antibodies and secondary therapy failure after treatment with botulinum toxin type A: much ado about nothing?.Clin Neuropharmacol. 2009; 32: 213-218
- Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy.Dermatol Surg. 2007; 33: S105-S110
- Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.Neurology. 1999; 53: 1431-1438
- Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.Dermatol Surg. 2003; 29: 516-518
- Botulinum toxin type B (MYOBLOC) versus botulinum toxin type A (BOTOX) frontalis study: rate of onset and radius of diffusion.Dermatol Surg. 2003; 29 (2nd): 519-522
- Anaesthesia with EMLA cream for botulinum A toxin injection into eyelids.Ophthalmologica. 2002; 216: 355-358
- Easing Botox administration with EMLA cream.Aesthet Surg J. 2004; 24: 79-81
- Efficacy of Botulinum toxin type A after topical anaesthesia.Ophthal Plast Reconstr Surg. 2006; 22: 448-545
- Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants.J Am Acad Dermatol. 2009; 61: 961-970
- Severe, intractable headache after injection with botulinum A exotoxin: a report of 5 cases.J Am Acad Dermatol. 2002; 46: 62-65
- Comparison of the spread of three botulinum toxin type A preparations.Arch Dermatol Res. 2011 Oct; ({Epub ahead of print})
- Dilution and storage of botulinum toxin.Dermatol Surg. 1998; 24: 1179-1180
- Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?.Dermatol Surg. 2007; 33: S97-104
- Effect of volume and concentration on the diffusion of botulinum exotoxin A.Arch Dermatol. 2004; 140: 1351-1354
- Complications and adverse reactions with the use of botulinum toxin.Dis Mon. 2002; 48: 336-356
- The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.Dermatol Online J. 2005; 11: 9-11
Allergan, Inc. Irvine, CA, USA Botox® Cosmetic; package insert.
Ipsen Biopharm Ltd., Wrexham, UK; package insert.
Merz Pharmaceuticals GmbH, Frankfurt, Germany; package insert.
- Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.Dermatol Surg. 1998; 24: 1216-1218
- Comparisons among Botulinum toxins: an evidence-based review.Plast Reconstr Surg. 2008; 121 (413e-22e)
- Duration of action of AbobotulinumtoxinA and OnabotulinumtoxinA.J Clin Aesthet Dermatol. 2011; 4: 43-49
- Noninferiority of incobotulinumtoxinA, free form complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.Dermatol Surg. 2010; 36: 2146-2154
- Botulinum toxins: the new expanded market.Plast Surg Pulse. 2009; 1: 1-6
- The quantitative assessment of wrinkle depth: turning the microscope on botulinum toxin type A.Ann Plast Surg. 2010; 65: 285-293
- Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study.Dermatol Surg. 1996; 22: 39-43
- Multicentre, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted up to six consecutive weeks before application.Dermatol Surg. 2003; 29: 23-29
- Foam during reconstitution does not affect the potency of botulinum toxin type A.Dermatol Surg. 2003; 29: 530-531
- Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomised controlled trial.Arch Dermatol. 2002; 139: 510-514
- Botulinum toxin: pharmacology and clinical developments: a literature review.Med Chem. 2007; 3: 333-345
- Botulinum treatment of strabismus in children.Trans Am Ophthalmol Soc. 1989; 87: 174-180
- Mechanism of botulinum toxin in the relief of chronic pain.Curr Rev Pain. 1999; 3: 427-431
- Effect of botulinum toxin type A on the capsule around a subpectoral implant for breast augmentation.Aesthet Plast Surg. 2009; 33: 782-783
- Botulinum toxin A and migraine surgery.Plast Reconstr Surg. 2003; 112 (171S–3S)
- Botulinum toxin as preventive treatment for migraine: a randomised double-blind study.Eur Neurol. 2009; 62: 204-211
- Treatment of depression with botulinum toxin A: a case series.Dermatol Surg. 2006; 32: 645-649
- Cosmetic use of botulinum toxin-A affects processing of emotional language.Psychol Sci. 2010; 21: 895-900
- A double-blind, randomised, placebo-controlled health-outcomes survey of the effect of botulinum toxin type A injections on quality of life and self-esteem.Dermatol Surg. 2010; 36: 2088-2097
http://www.telegraph.co.uk/health/healthnews/5609011/Botox-could-be-the-cure-for-baldness.html; [accessed 06.11.11].
- Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines.Dermatol Surg. 2010; 36: 2111-2118
- Characterisation of diffusion and duration of action of a new botulinum toxin type A formulation.Toxicon. 2011; 58: 159-167
- A comprehensive review of patient-reported satisfaction with botulinum toxin type A for aesthetic procedures.Plast Reconstr Surg. 2008; 122: 1915-1925
Article info
Publication history
Published online: May 01, 2012
Accepted:
April 9,
2012
Received:
November 11,
2011
Identification
Copyright
© 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Inc. All rights reserved.
